Olanzapine-Induced Neutropenia: Mechanism and Treatment [4]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 2, 2004, Pages 234-235

  Duggal, Harpreet S ^a   Gates, Charlie ^a   Pathak, Praveen C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; LITHIUM; OLANZAPINE; RISPERIDONE; VALPROIC ACID;

ADOLESCENT; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DROWSINESS; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; NEUTROPENIA; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOSIS; SYMPTOM;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; BLOOD CELL COUNT; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; NEUTROPENIA;

EID: 1642368891     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000117428.05703.16     Document Type: Letter

References (13)

1. Steinwachs A, Grohmann R, Pedrosa F, et al. Two cases of olanzapine-induced reversible neutropenia. Pharmacopsychiatry. 1999;32:154-156.
2. Dettling M, Cascorbi I, Hellweg R, et al. Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine. Pharmacopsychiatry. 1999;32:110-112.
3. Gajwani P, Tesar G. Olanzapine-induced neutropenia. Psychosomatics. 2000;41:150-151.
4. Teter CJ, Early JJ, Frachtling RJ. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric Institution. J Clin Psychiatry. 2000;61:872-873.
5. Kodesh A, Finkel B, Lerner G, et al. Dose-dependent olanzapine-associated leukopenia: three case reports. Int Clin Psychopharmacol. 2001;16:117-119.
6. Schuld A, Kraus T, Hinze-Selch D, et al. Granulocyte colony stimulating factor plasma levels during clozapine and olanzapine induced granulocytopenia. Acta Psychiatr Scand. 2000;102:153-155.
7. Xiaohong H, Xianxian W. Agranulocytosis and neutropenia with typical and atypical neuroleptics. Am J Psychiatry. 2001;158:1736-1737.
8. Konakanchi R, Grace JJ, Szarowicz R, et al. Olanzapine prolongation of granulocytopenia after clozapine discontinuation. J Clin Psychopharmacol. 2000;20:703-704.
9. Benedetti F, Cavallaro R, Smeraldi E. Olanzapine-induced neutropenia after clozapine-induced neutropenia. Lancet. 1999;354:567.
10. Felber W, Naumann R, Schuler U, et al. Are there genetic determinants of olanzapine-induced agranulocytosis? Pharmacopsychiatry. 2000;33:197-198.
11. Naumann R, Felber W, Heilemann H, et al. Olanzapine-induced agranulocytosis. Lancet. 1999;354:566-567.
12. Hartmann LC, Tschetter LK, Habermann TM, et al. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. New Engl J Med. 1997;336:1822-1824.
13. Mahmood T, Silverstone T, Spittle B. Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias. Int Clin Psychopharmacol. 1996;11:53-54.